AI Help for Dentists › Compare › Denti.AI vs Pearl

Denti.AI vs Pearl: affordable X-ray AI or the FDA-cleared name?

Both put AI on your radiographs, but they're aimed at different buyers. Denti.AI is the affordable, published-price read; Pearl is the FDA-cleared name with a polished patient overlay. Here's how to choose.

The short answer

If you're a solo or small practice that wants an AI second read without a sales process, start with Denti.AI: it reads X-rays from a published $49/mo. If the FDA clearance and a patient-facing overlay for case acceptance are worth a quote, and you can handle enterprise-style pricing, Pearl is the stronger name. Many small practices trial Denti.AI first and only move to an enterprise tool if they outgrow it.

Price and transparency

This is the clearest difference. Denti.AI publishes its pricing, $49/mo for Detect, $99/mo with Auto-Chart, so you can budget it in a minute. Pearl doesn't publish a price; it's a demo-and-quote process, usually with a setup fee, and third-party figures don't agree, so we don't cite one. Get Pearl's all-in quote and hold it against Denti.AI's public number.

Clearance, overlay, and who it's for

Pearl's Second Opinion is FDA-cleared for detecting pathology on radiographs and is built with a strong patient-facing overlay, which helps case presentation and is a common choice for growing groups standardizing a chairside read. Denti.AI covers the core read, decay and bone loss, plus optional auto-charting, at a price a single location can approve. Neither replaces your diagnosis; both are decision support you review.